Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jessie Bourcier"'
Autor:
Anne Lok, Julie Mocquard, Jessie Bourcier, Laurence Redelsperger, Antoine Bonnet, Cecile Chauvin, Patrick Thomaré, Beatrice Mahé, Cyrille Touzeau, Philippe Moreau
Publikováno v:
Haematologica, Vol 99, Iss 3 (2014)
Externí odkaz:
https://doaj.org/article/c8e8fbadd3064c6b9fa11c7d36c3c933
Autor:
Jan Philipp Bewersdorf, Maximilian F. Stahl, Justin Taylor, Namrata Sonia Chandhok, Justin Watts, Andriy Derkach, Mateusz Wysocki, Victoria Kostantakis, Sydney X. Lu, Jessie Bourcier, Simon Hogg, Tulasigeri M Totiger, Omar Abdel-Wahab, Eytan Stein
Publikováno v:
Blood. 140:9065-9067
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a903495c63cb521782a63f93aec031b
https://doi.org/10.1182/blood-2022-156830
https://doi.org/10.1182/blood-2022-156830
Autor:
Skye Montoya, Jessie Bourcier, Meghan C. Thompson, Mark Noviski, May Tan, Eric Wang, Xiaoli Mi, Nivetha Brathaban, Carla Barrientos Risso, Daniel Tsai, Jordan Ye, Jacob Jahn, Gabriel Pardo, Lee Cabuhat, Ryan Notti, Alejandro Pardo, Maurizio Affer, Stephanie Yung, James Luliano, Janine Powers, Daniel W Robbins, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M. Rhodes, Andrew D. Zelenetz, Lindsey E. Roeker, Hao Lu, Adam Linley, Anthony R. Mato, Omar Abdel-Wahab, Justin Taylor
Publikováno v:
Blood. 140:1811-1813
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76b956cafd37b3de71dc99029a09890a
https://doi.org/10.1182/blood-2022-163268
https://doi.org/10.1182/blood-2022-163268
Autor:
Jessie Bourcier, Simon J. Hogg, Caroline Erickson, Michael E Singer, Steven Tittley, Takahiro Ito, Anastasiya Egorova, Jason Kuttiyara, Alan M. Hanash, Omar Abdel-Wahab, Sydney X. Lu
Publikováno v:
Blood. 140:1163-1164
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88379d9ea92ef89df5d760476e210ec4
https://doi.org/10.1182/blood-2022-156727
https://doi.org/10.1182/blood-2022-156727
Autor:
Eric Wang, Xiaoli Mi, Meghan C. Thompson, Skye Montoya, Ryan Q. Notti, Jumana Afaghani, Benjamin H. Durham, Alex Penson, Matthew T. Witkowski, Sydney X. Lu, Jessie Bourcier, Simon J. Hogg, Caroline Erickson, Dan Cui, Hana Cho, Michael Singer, Tulasigeri M. Totiger, Sana Chaudhry, Mark Geyer, Alvaro Alencar, Adam J. Linley, M. Lia Palomba, Catherine C. Coombs, Jae H. Park, Andrew Zelenetz, Lindsey Roeker, Mary Rosendahl, Donald E. Tsai, Kevin Ebata, Barbara Brandhuber, David M. Hyman, Iannis Aifantis, Anthony Mato, Justin Taylor, Omar Abdel-Wahab
Publikováno v:
N Engl J Med
BACKGROUND: Covalent (irreversible) Bruton’s tyrosine kinase (BTK) inhibitors have transformed the treatment of multiple B-cell cancers, especially chronic lymphocytic leukemia (CLL). However, resistance can arise through multiple mechanisms, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c7a6941c3658b12d6cb8c107f22ac2
https://europepmc.org/articles/PMC9074143/
https://europepmc.org/articles/PMC9074143/
Autor:
Omar Abdel-Wahab, Jessie Bourcier
Publikováno v:
Blood cancer discovery. 3(2)
Summary:In this issue of Blood Cancer Discovery, Zheng and colleagues identify that alternative RNA splicing of CD22 within B-cell acute lymphoblastic leukemia can result in antigen escape from CD22-targeted immunotherapies. Drug-resistant isoforms o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f80fd01af276a29cf6e7f03fde854d97
https://pubmed.ncbi.nlm.nih.gov/35015683
https://pubmed.ncbi.nlm.nih.gov/35015683
Autor:
Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl, Simon J. Hogg, Jan Phillipp Bewersdorf, Cuijuan Han, Michael E. Singer, Daniel Cui, Caroline E. Erickson, Steven M. Tittley, Alexander V. Penson, Katherine Knorr, Robert F. Stanley, Jahan Rahman, Gnana Krishnamoorthy, James A. Fagin, Emily Creger, Elizabeth McMillan, Chi-Ching Mak, Matthew Jarvis, Carine Bossard, Darrin M. Beaupre, Robert K. Bradley, Omar Abdel-Wahab
Publikováno v:
Cancer Cell. 41:164-180.e8
Therapy resistance is a major challenge in the treatment of cancer. Here, we performed CRISPR-Cas9 screens across a broad range of therapies used in acute myeloid leukemia to identify genomic determinants of drug response. Our screens uncover a selec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8fc537c2ce087e5c5ed1cc59d902cbb
https://doi.org/10.1016/j.ccell.2022.12.002
https://doi.org/10.1016/j.ccell.2022.12.002
Autor:
Skye Montoya, Eric Wang, Jessie Bourcier, Sana Chaudhry, Tulasigeri Totiger, Alejandro Pardo, Gabriel Pardo, Maurizio Affer, Jacob Jahn, Anthony Mato, Omar Abdel-Wahab, Justin Taylor
Publikováno v:
Blood Cancer Discovery. 3:A04-A04
Bruton’s tyrosine kinase (BTK) is a target for multiple generations of covalent (irreversible) and non-covalent (reversible) inhibitors due to its critical role in the proliferation and survival of B-cell malignancies. Similar to drug resistance me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac94160662cf2a8ed4e1d2f48cd0b68c
https://doi.org/10.1158/2643-3249.lymphoma22-a04
https://doi.org/10.1158/2643-3249.lymphoma22-a04
Autor:
François Leclair, Jessie Bourcier, Cyrille Touzeau, Nelly Robillard, Camille Debord, Yannick Le Bris, François Subiger, Catherine Godon, Olivier Theisen, Soraya Wuilleme, Anne Moreau, Marie C. Béné, Thomas Gastinne
Publikováno v:
Annals of Hematology. 100:285-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::184ddac06dec7cc2c0a4b5a4920168bb
https://doi.org/10.1007/s00277-020-03989-5
https://doi.org/10.1007/s00277-020-03989-5
Autor:
Benoit Tessoulin, Philippe Moreau, Manuel S. Rodriguez, Jessie Bourcier, Antoine Bonnet, Patricia Gomez-Bougie, Sophie Maïga, Cyrille Touzeau, Martine Amiot, Catherine Pellat-Deceunynck, Steven Le Gouill
Publikováno v:
Blood. 132:2656-2669
BH3 mimetics are promising drugs for hematologic malignancies that trigger cell death by promoting the release of proapoptotic BCL2 family members from antiapoptotic proteins. Multiple myeloma is considered to be a disease dependent mainly on MCL1 fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e1394398c063abef83a06e9bf2b9ab4
https://doi.org/10.1182/blood-2018-03-836718
https://doi.org/10.1182/blood-2018-03-836718